Admission blood glucose and adverse outcomes in non-diabetic patients with myocardial infarction in the reperfusion era

International Journal of Cardiology

Volumn 113, Issue 2, 2006, Pages 229-235

  Meisinger, Christa ^a,b   Hörmann, Allmut ^b   Heier, Margit ^a,b   Kuch, Bernhard ^a   Löwel, Hannelore ^b  

^a KLINIKUM AUGSBURG   (Germany)

^b INSTITUTE OF EPIDEMIOLOGY   (Germany)

Author keywords

Blood glucose; Myocardial infarction; Prognosis; Reperfusion therapy

Indexed keywords

ADULT; AGED; ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GLUCOSE BLOOD LEVEL; HEART INFARCTION; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PERCUTANEOUS CORONARY INTERVENTION; POPULATION RESEARCH; PRIORITY JOURNAL; TREATMENT OUTCOME;

ADULT; AGED; BIOLOGICAL MARKERS; BLOOD GLUCOSE; FEMALE; FOLLOW-UP STUDIES; GERMANY; HUMANS; INCIDENCE; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION; MYOCARDIAL REPERFUSION INJURY; PATIENT ADMISSION; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 33751086776     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2005.11.018     Document Type: Article

References (33)

1. Malmberg K., and Ryden L. Myocardial infarction in patients with diabetes mellitus. Eur Heart J 9 (1988) 259-264
2. Behar S., Boyko V., Reicher-Reiss H., Goldbourt U., and SPRINT Study Group. Ten-year survival after acute myocardial infarction: comparison of patients with and without diabetes: secondary Prevention Reinfarction Israeli Nifedipine Trial. Am Heart J 133 (1997) 290-296
3. Löwel H., Koenig W., Engel S., Hörmann A., and Keil U. The impact of diabetes mellitus on survival after myocardial infarction: can it be modified by drug treatment? Results of a population-based myocardial infarction register follow-up study. Diabetologia 43 (2000) 218-226
4. Oswald G.A., Smith C.C.T., Betteridge D.J., and Yudkin J.S. Determinants and importance of stress hyperglycemia in non-diabetic patients with myocardial infarction. BMJ 293 (1986) 917-922
5. Bellodi G., Manicardi V., Malavasi V., et al. Hyperglycemia and prognosis of acute myocardial infarction in patients without diabetes mellitus. Am J Cardiol 64 (1989) 885-888
6. O'Sullivan J.J., Conroy R.M., Robinson K., Hickey N., and Mulcahy R. In-hospital prognosis of patients with fasting hyperglycemia after first myocardial infarction. Diabetes Care 14 (1991) 758-760
7. Norhammar A.M., Ryden L., and Malmberg K. Admission plasma glucose. Independent risk factor for long-term prognosis after myocardial infarction even in non-diabetic patients. Diabetes Care 22 (1999) 1827-1831
8. Bolk J., van der Ploeg T.J., Cornel J.H., Arnold A.E.R., Sepers J., and Umans VAWM. Impaired glucose metabolism predicts mortality after a myocardial infarction. Int J Cardiol 79 (2001) 207-214
9. Capes S.E., Hunt D., Malmberg K., and Gerstein H.C. Stress hyperglycemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview. Lancet 355 (2000) 773-778
10. Ceriello A. Acute hyperglycemia: a 'new' risk factor during myocardial infarction. Eur Heart J 26 (2005) 328-331
11. Sala J., Masiá R., González de Molina F.J., et al. Short-term mortality of myocardial infarction patients with diabetes or hyperglycaemia during admission. J Epidemiol Community Health 56 (2002) 707-712
12. Hadjadj S., Coisne D., Mauco G., et al. Prognostic value of admission plasma glucose and HbA1c in acute myocardial infarction. Diabet Med 21 (2004) 305-310
13. Wahab N.N., Cowden E.A., Pearce N.J., Gardner M.J., Merry H., Cox J.L., and The ICONS Investigators. Is blood glucose an independent predictor of mortality in acute myocardial infarction in the thrombolytic era?. J Am Coll Cardiol 40 (2002) 1748-1754
14. Stranders I., Diamant M., van Gelder R.E., et al. Admission blood glucose level as risk indicator of death after myocardial infarction in patients with and without diabetes mellitus. Arch Intern Med 164 (2004) 982-988
15. Foo K., Cooper J., Deaner A., et al. A single serum glucose measurement predicts adverse outcomes across the whole range of acute coronary syndromes. Heart 89 (2003) 512-516
16. Löwel H., Lewis M., Hörmann A., and Keil U. Case finding, data quality aspects and comparability of myocardial infarction registers: results of a South German register study. J Clin Epidemiol 44 (1991) 249-260
17. WHO MONICA Project (prepared by: Salomaa V, Dobson A, Miettinen H, Rajakangas A-M, Kuulasmaa K). Mild myocardial infarction-a classification problem in epidemiologic studies. J Clin Epidemiol 1997; 50(1):3-13.
18. The Joint European Society of Cardiology/American College of Cardiology Committee. Myocardial infarction redefined-a consensus document of The Joint European Society of Cardiology/American College of Cardiology for the redefinition of myocardial infarction. J Am Coll Cardiol 36 (2000) 959-969
19. Luepker R., Apple F.S., Christenson R.H., et al. Case definitions for acute coronary heart disease in epidemiology and clinical research studies. A statement from the AHA Council on Epidemiology and Prevention; AHA Statistics Committee; World Heart Federation Council on Epidemiology and Prevention; the European Society of Cardiology Working Group on Epidemiology and Prevention; Centers for Disease Control and Prevention; and the National Heart, Lung, and Blood Institute. Circulation 108 (2003) 2543-2549
20. Leor J., Goldbourt U., Reicher-Reiss H., Kaplinski E., Behar S., and The SPRINT Study Group. Cardiogenic shock complicating acute myocardial infarction in patients without heart failure on admission: incidence, risk factors, and outcome. Am J Med 94 (1993) 265-273
21. Husband D.J., Alberti K.G., Julian D.G., et al. "Stress" hyperglycemia during acute myocardial infarction: an indicator of pre-existing diabetes?. Lancet 2 (1983) 179-181
22. Sewardsen M., Vythilingum S., Jialal I., and Becker P.J. Prognostic importance of admission plasma glucose in diabetic and non-diabetic patients with acute myocardial infarction. Q J Med 265 (1989) 461-466
23. Kosiborod M., Rathore S.S., Inzucchi S.E., et al. Admission glucose and mortality in elderly patients hospitalized with acute myocardial infarction. Implications for patients with and without recognized diabetes. Circulation 111 (2005) 3078-3086
24. Tansey M.J.B., and Opie L.H. Plasma glucose on admission to hospital as a metabolic index of the severity of acute myocardial infarction. Can J Cardiol 2 (1986) 326-331
25. Thomassen A.R., Mortensen P.T., Nielsen T.T., Falstie-Jensen N., Thygesen K., and Henningsen P. Altered plasma concentrations of glutamate, alanine and citrate in the early phase of acute myocardial infarction in man. Eur Heart J 7 (1986) 773-778
26. Timmer J.R., van der Horst I.C.C., Ottervanger J.P., et al. Prognostic value of admission glucose in non-diabetic patients with myocardial infarction. Am Heart J 148 (2004) 399-404
27. Lakhdar A., Stromberg P., and McAlpine S.G. Prognostic importance of hyperglycaemia induced by stress after acute myocardial infarction. BMJ 288 (1984) 288
28. Vetter N.J., Strange R.C., Adams W., and Oliver M.F. Initial metabolic and hormonal response to acute myocardial infarction. Lancet i (1974) 284-288
29. Marfella R., Siniscalchi M., Esposito K., et al. Effects of stress hyperglycemia on acute myocardial infarction: role of inflammatory immune process in functional cardiac outcome. Diabetes Care 26 (2003) 3129-3135
30. Ceriello A. Coagulation activation in diabetes mellitus: the role of hyperglycemia and therapeutic prospects. Diabetologia 36 (1993) 1119
31. Ceriello D., Quatraro Giugliano.A., Dello Russo P., Marchi E., and Torella R. Hyperglycemia may determine fibrinopeptide A plasma level increase in humans. Metabolism 38 (1989) 1162-1163
32. Ceriello A., Giacomello R., Stel G., et al. Hyperglycemia-induced thrombin formation in diabetes. The possible role of the oxidative stress. Diabetes 44 (1995) 924-928
33. Williams S.B., Goldfine A.B., Timimi F.K., et al. Acute hyperglycemia attenuates endothelium-dependent vasodilation in humans in vivo. Circulation 97 (1998) 695-1701